Bartolo Colon Rumors
Since reviving his career with the Yankees in 2011, Bartolo Colon has only gotten better, and the right-hander tells Susan Slusser of the San Francisco Chronicle that he feels he can pitch for another three seasons. Colon added that if the A's are interested, he would like to return to Oakland for a third season (Twitter links).
Despite pitching most of the season at age 40, Colon enjoyed his finest season since 2005 with the Angels. Colon totaled 190 1/3 innings of 2.65 ERA ball, averaging 5.5 strikeouts and 1.4 walks per nine innings pitched with a 41.5 percent ground-ball rate. Colon's success is particularly intriguing given the fact that 85 percent of his pitches were either two-seam or four-seam fastballs.
Colon was mostly an afterthought from 2006-10 as he battled a host of shoulder and elbow injuries, but he underwent a stem cell treatment in the Dominican Republic in which doctors took fatty tissue and bone marrow from his hip and injected it into his ailing rotator cuff. Since then he's also been linked to PEDs, though he served a 50-game suspension last season, making it hard to imagine that he was using again in his superior 2013 campaign.
Colon earned just a $3MM base salary this year, though his contract reportedly contained incentives that could allow him to reach $5MM. Another one-year deal seems plausible as he enters his age-41 season, though his successful 2013 has likely earned him a raise. The A's are rich in young rotation options with the likes of Jarrod Parker, Sonny Gray, A.J. Griffin, Tommy Milone, Brett Anderson and Dan Straily, so it's unclear at this time whether retaining Colon's veteran presence will be of interest to general manager Billy Beane.
On this day in 2007, Terry Ryan announced that he would step aside from his post as the Twins general manager at the end of the season. As MLBTR's Tim Dierkes noted, Ryan's history was checkered at best at the time. Of course, as a read through this site's most recent post would indicate, Ryan is now back at the helm. Though the team has yet to post more than seventy wins in a season since Ryan returned in November of 2011, Minnesota stands at 15th in ESPN's latest future power rankings on the strength of its minor league system. While Ryan has long been said to have his job as long as he wants to keep it, some other GMs may not be so lucky ...
- There are four general managers around the league who could soon be replaced, writes Peter Gammons of GammonsDaily.com. According to Gammons, two of those -- Jerry Dipoto of the Angels and Larry Beinfest of the Marlins -- have arguably been undone by meddling owners. (Gammons cites Arte Moreno's $365MM investment in Albert Pujols and Josh Hamilton, and Jeffrey Loria's propensity for "whimsically run[ning] everything.") Meanwhile, Mariners GM Jack Zduriencik may not survive to see whether the team's top young pitching talent can drive a winner. And Rockies GM Dan O'Dowd -- the game's fourth-longest tenured GM -- has yet to figure out how to craft a squad that can win away from Coors field. (For what it's worth, O'Dowd was in charge for the franchise's lone season with a winning road record, when it posted a 41-40 mark in 2009.)
- It would be ridiculous to consider Rangers GM Jon Daniels among those at risk, writes Baseball Nation's Grant Brisbee. While he surely could have sacrificed future value to win at all costs this season, says Brisbee, Daniels was prudent not to and still delivered a team that should qualify for the post-season.
- Teams must determine whether to make outgoing free agents a qualifying offer just five days after the conclusion of this year's World Series, and those decisions will play a major role in setting the stage for the 2014 free agent market. For non-obvious candidates, writes Dave Cameron of Fangraphs, an important part of the equation lies in valuing the compensation pick that the team would receive if the player declines the offer and then signs with another club. Working off of a rough valuation of international signing slot dollars, Cameron opines that teams could value the dollars spent on a comp pick as much as three-to-four times higher than money the team could spend outside the draft. As he explains, this would imply that there is substantial excess value in obtaining non-marketable draft picks, which could move the needle in favor of making qualifying offers in marginal situations.
- As we prepare to weigh a new class of free agents, CBSSports.com's Jon Heyman ranks the best signings of 2013. His top three are a collection of veterans whose contributions have vastly outweighed the relatively meager financial commitments that they received: Pirates starter Francisco Liriano, Red Sox reliever Koji Uehara, and Athletics starter Bartolo Colon. Next on his list is Boston's David Ortiz, who as Heyman notes was the only player to accept a qualifying offer in the first year of the system.
Alex Rodriguez and 12 other players will be suspended for their involvement with Biogenesis, according to Jon Heyman of CBSSports.com. Earlier today, we learned Rodriguez is to be suspended through the 2014 season and Heyman names Tigers shortstop Jhonny Peralta, Rangers outfielder Nelson Cruz, Mariners catcher Jesus Montero, Padres shortstop Everth Cabrera, and Yankees catcher Francisco Cervelli among the Major League players also expected to be suspended, as well as minor leaguers Fernando Martinez, Jordan Norberto, Fautino de los Santos, and Cesar Puello. Heyman adds there are also three players on the suspension list whose names have yet to become public.
Heyman writes Blue Jays outfielder Melky Cabrera, A's right-hander Bartolo Colon, and Padres catcher Yasmani Grandal will not be suspended in connection with Biogenesis, as they have served 50-game penalties already.
All or almost all of the other 12 players are expected to accept 50-game suspensions, though there could be an additional holdout or two for appeal beyond Rodriguez, reports Heyman. All the players have the option to appeal, but it is believed close to all of them have made agreements for 50-game bans with MLB, Heyman adds. Players who appeal are eligible to keep playing until their case is heard.
Cruz told reporters, including MLB.com's T.R. Sullivan, "I haven't decided what I'm going to do about anything. It's not just about myself, it's also about the team." Today is the 112th game played by the Rangers, so Cruz would be eligible to return for the playoffs (assuming Texas reaches the post-season), if he serves a 50-game suspension beginning Monday. Sullivan surmises the Rangers will recall an outfielder from the minors adding Manny Ramirez is not an option and manager Ron Washington is reluctant to use Jurickson Profar in the outfield. Regardless of what the Rangers end up doing, assistant GM Thad Levine acknowledges, "At this stage of the season, that's a difficult bat to replace."
12:33am: Cruz has not decided whether he will serve his suspension or appeal it, according to Jeff Wilson of the Fort Worth Star-Telegram (on Twitter).
7:17pm: Major League Baseball is preparing 50-game suspensions for Biogenesis-linked players who have not been disciplined in the past, writes Jon Heyman of CBS Sports.
Players such as Nelson Cruz, Jhonny Peralta, Everth Cabrera, Jesus Montero and Francisco Cervelli are among those facing these 50-game suspensions, as are minor leaguers Fernando Martinez, Cesar Puello and Fautino de los Santos. Jeff Passan of Yahoo Sports writes that the vast majority of players connected to these 50-game suspensions -- including playoff contenders Cruz and Peralta -- are believed to be willing to accept the punishment rather than file appeals. Doing so will allow suspended players to play toward the end of September and into the playoffs, though their teams would be at a significant disadvantage down the stretch
Passan also tweets that MLB has threatened to double the penalty for players who do not cooperate with the suspensions, making cooperation a much more appealing option. Additionally, he adds that players who lied during the investigation could receive an additional 15 games on their suspensions, similar to Ryan Braun's case (Twitter link).
Bartolo Colon, Melky Cabrera and Yasmani Grandal are not likely to receive additional suspensions, having already served 50-game bans, according to Heyman. Both Heyman and Passan agree that Alex Rodriguez remains firm in his refusal to cooperate with a deal, as was reported earlier today. MLB would like Rodriguez to serve a suspension through the 2014 season but could pursue a lifetime ban if he does not cooperate.
Yesterday, Joel Sherman and Ken Davidoff of the New York Post reported "the strong indications are Major League Baseball will announce all the suspensions in the Biogenesis case this week." No announcement from MLB is expected today, tweets Steven Marcus of Newsday. Wednesday's trade deadline is "no factor when it comes to the timing of announcements related to the case," hears Jon Heyman of CBS Sports. We could be in for a wild week. The latest on Biogenesis:
- MLB is willing to offer Rodriguez a suspension of the rest of this year and all of 2014, report Bill Madden, Teri Thompson, and Michael O'Keefe of the New York Daily News, and if he declines, MLB is expected to attempt to ban him for life. Over at River Ave. Blues, Mike Axisa runs through different scenarios involving A-Rod.
- The Yankees have continued to search for third base help, but Heyman says that isn't necessarily tied to the possibility A-Rod gets suspended. Though first-time offenders are permitted to play during an appeals process, baseball might challenge that practice in the case of Rodriguez, writes Rosenthal.
- The Tigers have shown no indication they are looking for a shortstop replacement, writes Heyman. "I would think Detroit would want a shortstop, but we'll see," an NL GM told Heyman. Neither Peralta nor Nelson Cruz has indicated to his team a plan in case of a suspension, writes Yahoo's Jeff Passan. It's possible those two will be faced with choosing their current team (appealing a suspension into next year) or choosing to preserve their free agent value (serving a 50-game suspension now). I imagine taking what might be perceived as the selfish route, serving the suspension now, could hurt free agent stock in its own right.
- As you might expect, the Rangers prefer a prolonged appeals process for Cruz, writes Bob Nightengale of USA Today. Nightengale wonders, "If Cruz goes down without a fight and accepts his penalty, why would they want a guy back who quit on the organization?" That question would apply to Cruz potentially returning for the playoffs, as well as signing a new deal with the Rangers in the offseason. Cruz might have to settle for a less lucrative two-year free agent deal similar to that of Melky Cabrera, one GM estimated to Heyman.
- Since Colon already completed a 50-game suspension for PED use, A's people are expressing confidence he won't get another suspension, writes Heyman, and Ken Rosenthal of FOX Sports also hears the same. The team's pursuit of Jake Peavy is unrelated.
- "If drug dealers can use the currency of player evidence as a means to gain immunity and even more money, then our system of policing and protecting baseball has incentivized the people and the very behavior that was the genesis of the problem," agent Scott Boras tells Rosenthal. Baseball cut a deal with Biogenesis owner Anthony Bosch that provides many protections.
- In dealing with Jason Giambi, the Yankees concluded they cannot void a contract based on PED use, writes ESPN's Buster Olney. Some lawyers, however, wonder if a team could file a lawsuit against a player alleging damage to their brand.
Major League Baseball has ruled that Cuban shortstop Aledmys Diaz is ineligible to sign until February 2014, Ben Badler of Baseball America reports. Diaz had claimed to be born in January 1990, which would make him 23 and would mean MLB teams wouldn't be restricted by their international bonus pools in their attempts to sign him. Earlier media reports indicate that he is actually 22. A 22-year-old Cuban player would still have to sign under the bonus pool system. Ten teams were reported to have interest in Diaz. Here are more notes from around the Majors.
- The White Sox's Jake Peavy says he wanted to ask the team if he could pitch for the big league club on Sunday, though he would have been denied, Mark Gonzales of the Chicago Tribune reports via Twitter. Peavy, who's been sidelined with a rib injury, will join the Sox's Double-A club on Wednesday if he's still feeling good at that time, Gonzales says. If he's healthy, Peavy could be a trade chip at the July 31 deadline.
- Bartolo Colon is defying the odds yet again this season with the Athletics, Tyler Kepner of the New York Times writes. Colon currently has a 2.69 ERA with 4.9 K/9 and 1.1 BB/9 in 120 1/3 innings despite his age (40) and the fact that he was suspended last season for testing positive for testosterone. Common sense suggested that, without the use of PEDs, Colon couldn't keep pitching well, but the A's took a chance on Colon, signing him for $3MM plus bonuses. "Our organization thought he would be very similar based on what they saw in winter ball," says A's manager Bob Melvin. "He was throwing with the same velocity he does right now, the same movement. It was an easy sign for us and we did it very quickly, based on what everybody thought he would be like, and certainly he’s been that and more."
- The Giants' signing of Jeff Francoeur is a "lightning-in-a-bottle play," Andrew Baggarly of CSNBayArea.com writes. Baggarly compares the acquisition to the Giants' May 2010 signing of Pat Burrell, who had been cast off by the Rays. Baggarly also notes that Francoeur and Kensuke Tanaka, who is making his big-league debut while starting in left field Tuesday night, will mean less playing time for Andres Torres.
Aaron Steen contributed to this post.
9:46pm: Besides Braun and Rodriguez, "other major, major names" are also involved in the Biogenesis case, a source tells Bob Klapsich of the Bergen Record (Twitter link).
6:56pm: Major League Baseball is planning to suspend at least 20 players connected to Biogenesis, the Miami clinic under investigation for supplying performance-enhancing drugs, reports T.J. Quinn, Pedro Gomez and Mike Fish of ESPN's Outside The Lines. Biogenesis founder Tony Bosch has agreed to cooperate with the investigation and begin naming players, with suspensions possibly following within two weeks.
The list of possible suspensions includes Alex Rodriguez, Ryan Braun, Melky Cabrera, Nelson Cruz, Bartolo Colon, Yasmani Grandal, Francisco Cervelli, Jesus Montero, Jhonny Peralta, Cesar Puello, Fernando Martinez, Everth Cabrera, Fautino de los Santos and Jordan Norberto, plus others who are named in documents that the ESPN team haven't had access to, or are known under code names.
MLB officials have also investigated a possible connection between Biogenesis and Yankees second baseman Robinson Cano, as the spokeswoman for Cano's foundation (Sonia Cruz) has had her name appear in some clinic documents. Nationals southpaw Gio Gonzalez isn't expected to face suspension for his connection to Biogenesis since the products he obtained from the clinic weren't banned.
The league could look for a 100-game suspension (the penalty for second-time PED offenders) for Rodriguez, Braun and other first-time offenders since both the connection to Biogenesis and previous denials to MLB officials would serve as seperate offenses. It is unknown how MLB would deal with players like Cabrera or Colon who already have PED suspensions on their record, though these players probably wouldn't face a lifetime ban as three-time offenders -- their prior suspensions would likely count as their so-called "first strike," with this next violation putting them in line for 100-game suspensions as well.
Quinn/Gomez/Fish report that, as expected, the accused players will challenge any possible suspensions and it could be difficult for the league to obtain corroborating evidence in the appeals process beyond Bosch's testimony.
With one-fourth of the season in the books, let's have a look around some injury situations and how they might impact the developing trade market.
- The Cardinals and Yankees provide an interesting case study as we enter the second quarter of the season. Both have excellent records and lead their division. Both have sizeable payrolls as well as large portions of those payrolls sitting idle on the DL. Both have had to insert players onto their active roster that they did not anticipate. But, as Derrick Goold of the St. Louis Post-Dispatch well explains, the source of those substitute bodies has been drastically different. While the Yankees spent well over $20MM to bring in players like Lyle Overbay, Kevin Youkilis, Travis Hafner, and Vernon Wells -- all of whom are 34 or older -- the Cards reached into their minor league system. Remarkably, St. Louis has plugged all of its holes with players making league minimum, including young pitchers John Gast, Shelby Miller, and Seth Maness.
- The Goold piece also includes some valuable insight from GM John Mozeliak. According to Mozeliak, amongst the team's Double-A and Triple-A rosters, "there is almost at any one position, if we needed help at the big leagues, someone we could call on from there." He acknowledges that such cheap, youthful depth cannot always be achieved, and says the team is prepared to pursue other markets as necessary. "I don't want us to go down the path where we feel like we've created this functional model and don't utilize a really robust pro scouting model that makes sure we understand the trade market and understand the free agent market. We can't be scared of those." Yet, by looking internally first, the team has managed to retain salary flexibility to add outside impact down the line. "This organization's way now of staying healthy is not being tied to those outside markets to fill needs," says Mozeliak. "Having some young players step up like they are now gives us additional flexibility when we're going to need it."
- The Cards' internal depth will once again be put to use with starter Jaime Garcia now staring at a strong possibility of season-ending shoulder surgery, writes Goold. Even with fellow starter Jake Westbrook also stuck on the DL, the team has multiple options among its current relief corps and Triple-A rotation that make a look outside the organization unlikely. Of course, it remains to be seen whether Garcia's replacement(s) can match his strong start to the year. He had thrown 55 1/3 innings of 3.58 ERA baseball to open the season. Veteran starter Chris Carpenter is increasingly shaping up as a viable mid-season option for the club. But any setback in his surprising recovery, or hiccups among the team's young hurlers, could lead St. Louis to consider eventually utilizing some of its salary reserves and young minor league depth in a trade.
- The Braves are another National League contender dealing with injured arms. As Matt Snyder of CBSSports.com's Matt Snyder writes, Eric O'Flaherty appears likely to join fellow setup man Jonny Venters as a season-ending Tommy John patient. While the team seems likely to utilize internal options to fill in for the present, the loss of its two late-inning lefties leaves the team with just one southpaw in the pen, Luis Avilan. Ultimately, then, Atlanta could be forced to explore the trade market to re-establish its depth as the season wears on.
- Teams shopping for starters at the trade deadline appear likely to find a limited supply of attractive arms, says ESPN.com's Buster Olney (Insider subscription required). Two Cubs pitchers headline the developing market, with Scott Feldman shaping up as the surprise top option at the moment. (Matt Garza, of course, will begin his potential audition on Tuesday.) In addition to several other well-documented trade candidates in Ricky Nolasco of the Marlins and the Astros' Bud Norris and Lucas Harrell, Olney pegs the Padres' Jason Marquis and Edinson Volquez as likely available. Meanwhile, Bartolo Colon of the Athletics and Cliff Lee of the Phillies could also be dealt, writes Olney, with the A's having other internal options and the Phils still weighing how to proceed with their excellent (but expensive) 35-year-old co-ace.
Gio Gonzalez and Nelson Cruz are among the MLB stars who have been linked to a supplier of performance enhancing drugs in a report from Tim Elfrink of the Miami New Times. A Miami-based clinic sold PEDs to athletes from various sports, according to the report. The names of Cruz, Gonzalez, Alex Rodriguez, Melky Cabrera and Bartolo Colon were found in the records at Biogenesis, an anti-aging clinic located near the University of Miami.
Gonzalez's name appears five times in the notebooks of Anthony Bosch, the clinic's chief. Cruz purchased $4,000 of product, according to the report. Rodriguez's name appears throughout the clinic's files, while Cabrera's name appears 14 times and Colon’s name also comes up.
Gonzalez has considerable security after agreeing to a five-year, $42MM contract with the Nationals last offseason. He'll earn $6.25MM in 2013 and remains under contract through 2016. Cruz will earn $10.5MM this year then hit free agency following the 2013 season. Cabrera, 28, signed a two-year, $16MM contract with the Blue Jays after serving a PED-related suspension at the end of the 2012 season. Colon, who has also served a PED-related suspension, signed a one-year, $3MM deal with the Athletics this offseason.
Rodriguez could face a suspension, Bob Nightengale of USA Today reports. However, don't expect the Yankees to be able to void the third baseman's contract. As Yahoo's Jeff Passan reports, the Yankees weren't able to void the deal after he admitted to using performance enhancing drugs for the first time (Twitter link). Rodriguez, who will miss much of the 2013 season recovering from a hip operation, has $114MM remaining on his contract with the Yankees.
SUNDAY: The incentives in Colon's contract include provisions should he pitch in relief, according to the San Francisco Chronicle's Susan Slusser. Moving Colon to the bullpen would allow the A's to use other relievers as trade bait, opines Slusser.
SATURDAY 9:37pm: Joe Stiglich of The Bay Area News Group reports (on Twitter) that the deal could be worth more than $5MM if Colon hits all of his incentives.
4:15pm: Colon's deal has a base salary of $3MM with a good incentives package, a source tells Susan Slusser of the San Francisco Chronicle (via Twitter).
3:20pm: The A’s announced that they have re-signed right-handed pitcher Bartolo Colón to a one-year contract. Terms of the deal are not yet known for the Wasserman Media Group client.
Colon turned in a 3.43 ERA with 5.4 K/9 and 1.4 BB/9 through 24 starts before a positive test for testosterone landed him a 50-game suspension in August. The 39-year-old still must serve five games of that suspension in 2013.
The right-hander made just 47 starts from 2006-2009 and missed the 2010 season but turned in a strong 2011 for the Yankees. For his career, Colon has a 4.05 ERA with 6.9 K/9 and 2.9 BB/9.
Mike Axisa and Edward Creech contributed to this post.